Skip to main content
. 2020 Oct 14;20(6):197. doi: 10.3892/etm.2020.9327

Table II.

Risk analysis.

Exposure+/- Disease presence Disease absence    
Scenarios SBP130 mm Hg SBP ≤130 mm Hg Patients Statistics
Scenario 1        
     NAFLD+ 21 48 69 P=0.000025
     NAFLD- 3 71 74 OR=10.35
     Total 24 119 143 OR∈ (2.93; 36.65)
Scenario 2 DBP >80 mm Hg DBP ≤80 mm Hg - -
     NAFLD+ 23 46 69 P=0.00028
     NAFLD- 6 68 74 OR=5.66
     Total 29 114 143 OR∈ (2.14; 14.99)
Scenario 3 HOMA-IR >4 HOMA-IR ≤4 - -
     NAFLD+ 31 38 69 P=0.00009
     NAFLD- 11 63 74 OR=4.67
     Total 42 101 143 OR∈ (2.10; 10.36)
Scenario 4 HOMA%B <122 HOMA%B ≥122 - -
     NAFLD+ 44 25 69 P=0.0043
     NAFLD- 29 45 74 OR=2.73
     Total 73 70 143 OR∈ (1.39; 5.38)
Scenario 5 HOMA%S >53 HOMA%S ≤53 - -
     NAFLD+ 40 29 69 P≤0.001
     NAFLD- 12 62 74 OR=7.13
     Total 52 91 143 OR∈ (3.26; 15.59)

NAFLD, non-alcoholic fatty liver disease; DBP, diastolic blood pressure; OR, odds ratio.